2028 年幽门螺杆菌 (H. pylori) 非侵入性检测市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00005185
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 177
Buy Now

 

幽门螺杆菌(H. pylori)无创检测市场预计将从 2021 年的 5.9682 亿美元增长到 2028 年的 8.0004 亿美元;预计 2022 年至 2028 年的复合年增长率为 4.4%。

幽门螺杆菌感染率的上升和技术的进步正在推动整个市场的增长。此外,主要参与者实施的战略为全球市场提供了有利可图的机会。

幽门螺杆菌(HP)是导致消化性溃疡和胃炎的主要因素。根据公共科学图书馆(PLOS)的报告,北欧和北美大约三分之一的成年人感染了幽门螺杆菌,非洲、南美洲和中美洲、亚洲以及南欧和东欧的感染率非常高,达到50%。此外,成年人的幽门螺杆菌感染率也很高,但存在一些地域差异。例如,美国国立卫生研究院(NIH)的报告指出,青少年中幽门螺杆菌的感染率为30-50%,而在发展中国家的成年人中,感染率高达90%。

临床和实验儿科 (CEP) 报告指出,幽门螺杆菌感染的患病率有所下降。根据同一份报告,尽管韩国和发达国家的幽门螺杆菌感染率有所下降,但全球仍有 33% 的无症状或健康儿童在血清学上受到感染。例如,日本、德国、荷兰和美国等发达国家报告的血清流行率较低,2020 年分别为 7.7%、11.8%、9.8% 和 5.7%。然而,同年智利、委内瑞拉、伊朗和尼日利亚报告的感染率分别为 27.2%、65.9%、25.8% 和 40.4%。因此,幽门螺杆菌感染患病率的上升加速了对非侵入性检测的需求,最终推动预测期内幽门螺杆菌 (H. pylori) 非侵入性检测市场的增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

幽门螺杆菌 (H. pylori) 非侵入性检测市场:

幽门螺杆菌(H. pylori)无创检测市场
  • Helicobacter Pylori (H. pylori) Non-Invasive Testing Market
    复合年增长率(2021 - 2028 年)
    4.4%
  • 2021 年市场规模
    5.9682 亿美元
  • 市场规模 2028 年
    8.0004 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 迪亚索林公司
  • Meridian Bioscience 公司
  • QuidelOrtho 公司
  • 雅培实验室
  • CerTest Biotec
  • 赛默飞世尔科技公司
  • 积水诊断
  • Coris BioConcept
  • 深圳市中和海德威生物科技有限公司

区域概况

Helicobacter Pylori (H. pylori) Non-Invasive Testing Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Helicobacter Pylori (H. pylori) Non-Invasive Testing Market测试类型
  • 血清学
  • 粪便抗原
  • 尿素呼吸
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market测试方法
  • 实验室和床旁检测
Helicobacter Pylori (H. pylori) Non-Invasive Testing Market最终用户
  • 医院
  • 诊所
  • 诊断实验室
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

幽门螺杆菌 (H. pylori) 是一种细菌感染,主要在患有胃溃疡和十二指肠溃疡的患者中发现。例如,疾病控制和感染中心 (CDC) 报告指出,全球幽门螺杆菌感染的患病率约为 50%,发展中国家约为 80-90%。此外,在美国,幽门螺杆菌的患病率估计为 35-40%。幽门螺杆菌感染的高患病率对采用非侵入性诊断解决方案产生了积极影响。幽门螺杆菌非侵入性检测解决方案的技术进步和创新为患有细菌感染的患者提供了准确的结果和更高的患者满意度。例如,即时检测 (POCT) 可以在短时间内以实惠的价格提供准确的结果。由于患有多种健康状况的人通常更容易受到感染并寻求早期发现幽门螺杆菌感染,因此 POCT 的可及性提高以及大量侵入性和非侵入性设备的易用性对市场增长产生了积极影响。例如,2022 年 5 月,Biomerica, Inc. 宣布推出一款新产品,用于其用于检测幽门螺杆菌的“hp+detect”诊断测试的 CE 标志。新产品“hp+detect”产品用于检测幽门螺杆菌,幽门螺杆菌在美国人口中的患病率为 35%,在欧洲五大国中的患病率为 45%。

低诊断率是幽门螺杆菌(H. pylori)非侵入性检测市场的主要制约因素。社会经济地位低或教育水平低与幽门螺杆菌感染的患病率增加有关。在澳大利亚,估计普通人群的幽门螺杆菌汇总患病率为 24.6%,但在西澳大利亚农村土著社区的患病率高达 76.0%。在美国,估计普通人群的幽门螺杆菌汇总患病率为 35.6%,但在阿拉斯加土著人口中则为 74.8%。幽门螺杆菌(H. pylori)感染率高是因为其在较长时间内无症状,所以这种感染的诊断率较低。大多数感染幽门螺杆菌的人没有症状。这个问题可能会延迟感染的诊断,从而限制对非侵入性检测试剂盒的需求。

 

幽门螺杆菌 (H. pylori) 非侵入性检测市场 - 区域概览

中国在亚太地区幽门螺杆菌 (H. pylori) 非侵入性检测市场占有相当大的份额。中国是亚太地区的发展中国家,拥有完善的医疗保健体系和快速发展的制药业。中国是全球市场上各种医疗、制药和生物技术产品制造公司的所在地。由于各种幽门螺杆菌感染和胃癌病例的患病率很高,这些制药和生物技术公司参与开发用于幽门螺杆菌检测的各种检测试剂盒和设备,从而推动了市场的增长。

日本是医疗行业最先进的领先国家之一。根据罗斯威尔帕克综合癌症中心的数据,由于幽门螺杆菌感染率高以及烟熏和腌制食品消费量高,日本的胃癌发病率异常高。此外,胃癌是第三大致命癌症,在日本每年导致约 50,000 人死亡。此外,根据威利在线图书馆发表的一项研究 (2020),幽门螺杆菌是日本约 98% 胃癌的病因。尽管已报告的胃癌病例原因有很多,但最近的研究表明,大多数胃癌发病率是由于幽门螺杆菌感染引起的。预计上述因素将在预测期内对日本幽门螺杆菌 (H. pylori) 无创检测市场增长产生积极影响。

 

幽门螺杆菌 (H. pylori) 非侵入性检测市场 - 基于检测类型的洞察

根据检测类型,幽门螺杆菌 (H. pylori) 非侵入性检测市场细分为血清学、粪便抗原和尿素呼吸。尿素呼吸部分估计在 2022 年至 2028 年期间将占据最大的市场份额和最高的复合年增长率。根据美国国立卫生研究院 (NIH) 的报告,非侵入性 H. pylori 诊断测试可用于初级保健的即时诊断 (POC),包括 IgG 血清学、13C-尿素呼气试验 (UBT) 和单克隆粪便抗原。其中,只有 UBT 可以准确确认当前感染或根除。《肠道和肝脏》报告显示,UBT 对儿科患者和孕妇来说是非侵入性的、准确的、安全的。因此,上述因素可能会推动该细分市场在 2022 年至 2028 年期间的市场增长。

在幽门螺杆菌(H. pylori)非侵入性检测市场运营的公司采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在市场上保持自己的品牌名称。

 

幽门螺杆菌 (H. pylori) 非侵入性检测市场 – 细分

根据检测类型,幽门螺杆菌 (H. pylori) 非侵入性检测市场细分为血清学、粪便抗原和尿素呼吸。尿素呼吸部分在 2021 年占据了最大的市场份额,预计在 2022 年至 2028 年期间将实现最高复合年增长率。根据测试方法,市场分为基于实验室和即时诊断。基于实验室的细分市场在 2021 年引领了市场,预计在预测期内将保持主导地位。根据最终用户,市场细分为医院、诊所和诊断实验室。医院细分市场在 2021 年引领了市场,预计在预测期内将保持主导地位。根据地理位置,市场主要细分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。

 

幽门螺杆菌无创检测市场报告范围

报告属性细节
2021 年市场规模5.9682亿美元
2028 年市场规模8.0004亿美元
全球复合年增长率(2021 - 2028)4.4%
历史数据2019-2020
预测期2022-2028
涵盖的领域按测试类型
  • 血清学
  • 粪便抗原
  • 尿素呼吸
按测试方法
  • 实验室和床旁检测
按最终用户
  • 医院
  • 诊所
  • 诊断实验室
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 迪亚索林公司
  • Meridian Bioscience 公司
  • QuidelOrtho 公司
  • 雅培实验室
  • CerTest Biotec
  • 赛默飞世尔科技公司
  • 积水诊断
  • Coris BioConcept
  • 深圳市中和海德威生物科技有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

幽门螺杆菌 (H. pylori) 非侵入性检测市场 - 公司简介

  • DiaSorin SpA,
  • Meridian Bioscience 公司
  • QuidelOrtho 公司,
  • 雅培实验室,
  • 赛默飞世尔科技,
  • CerTest Biotec,
  • 积水诊断
  • Coris BioConcept,
  • 深圳市中和海德威生物科技有限公司
  • Bio-Rad 实验室有限公司
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the regional market scenario of the Helicobacter pylori (H. pylori) non-invasive testing market?

Global Helicobacter pylori (H. pylori) non-invasive testing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for H. pylori non-invasive testing market. The growing prevalence of stomach cancer, duodenal ulcers, and gastric ulcers and the development of health care facilities will drive H. pylori non-invasive testing market growth in North America. Further, the rising geriatric population, high prevalence of H. pylori, gastric cancer cases, and expanding partnerships among key players are the key factor responsible for the Asia-Pacific regional growth for H. pylori non-invasive testing market accounting fastest growth of the region during the coming years.

Who are the key players in the Helicobacter pylori (H. pylori) non-invasive testing market?

DiaSorin S.p.A., Meridian Bioscience, QuidelOrtho Corporation, Abbott, Thermo Fisher Scientific, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., and Bio-Rad Laboratories, Inc. are among the leading companies operating in the H. pylori non-invasive testing market.

Which end user segment held the largest market share in the Helicobacter pylori (H. pylori) non-invasive testing market?

The diagnostic laboratories segment dominated the global Helicobacter pylori (H. pylori) non-invasive testing market and accounted for the largest market share of 59.01% in 2021.

Which test type segment led the Helicobacter pylori (H. pylori) non-invasive testing market?

Based on test type, the urea breath segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which test method segment held the largest market share in the Helicobacter pylori (H. pylori) non-invasive testing market?

Based on the test method, laboratory-based test method segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

What is meant by the Helicobacter pylori (H. pylori) non-invasive testing market?

Helicobacter pylori (H. pylori) is a very motile, spiral, or curved rod-shaped Gram-negative bacteria comprising multiple flagella that live in the gastric mucous-coated lining and the gastric pits of the epithelial tissue of the stomach and/or duodenum. Currently, non-invasive tests are the first methods for diagnosing H. Pylori infection. These tests include serological tests, stool antigen research, and urea breath test.

What are the driving factors for the Helicobacter pylori (H. pylori) non-invasive testing market across the globe?

Increasing prevalence of H. pylori bacterial infection and new product launches and FDA approvals are the most significant factors responsible for the overall market growth.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Helicobacter Pylori (H. pylori) Non-invasive Testing Market

  1. DiaSorin S.p.A.
  2. Meridian Bioscience Inc.
  3. QuidelOrtho Corporation
  4. Abbott Laboratories
  5. CerTest Biotec
  6. Thermo Fisher Scientific Inc.
  7. Sekisui Diagnostics
  8. Coris BioConcept
  9. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  10. Bio-Rad Laboratories Inc.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.